Change-Impact Assessment for In Vitro Diagnostic R&D Modules
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing in vitro diagnostic reagent products face challenges in developing customized products for various diseases, require multiple testing equipment, and struggle with standardized research and development processes, leading to difficulties in performing comprehensive diagnostic tests in primary and secondary hospitals.
Innovation Solution
A research and development management device and method that enables external user accounts to use a standardized research and development module, allowing for the development and production of various in vitro diagnostic reagent products, with data-driven updates based on research and clinical data, using algorithms for oligonucleotide design, amplification data processing, and equipment operation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If multiple testing equipment are used for different diagnostic tests, then comprehensive diagnostic capability is improved, but device complexity and operational difficulty increase
Solution Approach 1:
The patent implements a universal testing platform that can perform multiple diagnostic tests (ELISA, PCR, sequencing) using a single integrated system. The platform includes common components such as sample processing modules, detection modules, and data analysis systems that can be configured for different test types, eliminating the need for separate specialized equipment for each diagnostic method.
Solution Approach 2:
The patent combines previously separate testing workflows into an integrated system where sample preparation, nucleic acid extraction, amplification, detection, and data analysis are merged into a coordinated process. This integration allows different diagnostic tests to share common infrastructure and operational procedures, reducing overall system complexity.
2Productivity
If standardized research and development processes are implemented, then production efficiency is improved, but flexibility in developing customized products decreases
Solution Approach 1:
The patent implements a dynamic R&D platform where standardized processes provide a consistent foundation, but the system allows flexible configuration of test parameters, reagent combinations, and analysis protocols. This enables the same standardized platform to adapt to customized product requirements through programmable controls and configurable workflows rather than requiring separate development processes for each product type.
Solution Approach 2:
The patent utilizes parameter-based configuration where standardized R&D processes can be adjusted by changing operational parameters (temperature profiles, reaction times, reagent concentrations, detection thresholds) to accommodate different diagnostic tests and customized products. This allows efficient standardization while maintaining adaptability through parameter optimization rather than process redesign.
3Measurement precision
If data-driven updates are performed on algorithms, then diagnostic accuracy is improved, but system reliability may be affected by frequent changes
Solution Approach 1:
The patent implements a feedback mechanism where diagnostic results and performance data are continuously monitored and fed back to the system. This allows algorithms to be updated based on actual performance metrics and clinical outcomes, improving diagnostic accuracy over time. The feedback loop includes validation steps that ensure updates maintain or improve system reliability rather than introducing instability.
Solution Approach 2:
The patent performs preliminary validation and testing of algorithm updates before deploying them to the production system. Update candidate content is assessed through change impact analysis and verified against test data sets to ensure accuracy improvements do not compromise system reliability. This preliminary action prevents unstable algorithms from being deployed and maintains system trustworthiness.
Data Source
AI summary
A method and a device for updating a research and development module are proposed. The method may include obtaining research and development data of an in vitro diagnostic reagent product generated by the research and development module used by an external user account and/or clinical data of the in vitro diagnostic reagent product. The method may also include obtaining update candidate content for the research and development module determined on the basis of at least a portion of the obtained research and development data and the clinical data. The method may further include obtaining a result generated by performing change impact assessment of the update candidate content on the research and development module. The method may further include controlling the research and development module to be updated in response to the result generated by performing the change impact assessment.